{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T22:35:16Z","timestamp":1785191716326,"version":"3.55.0"},"reference-count":69,"publisher":"The Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,2,1]]},"DOI":"10.1210\/jc.2016-2271","type":"journal-article","created":{"date-parts":[[2016,12,14]],"date-time":"2016-12-14T19:01:47Z","timestamp":1481742107000},"page":"363-374","source":"Crossref","is-referenced-by-count":49,"title":["Clinical Features and Management of Non-HIV\u2013Related Lipodystrophy in Children: A Systematic Review"],"prefix":"10.1210","volume":"102","author":[{"given":"Nidhi","family":"Gupta","sequence":"first","affiliation":[{"name":"Evidence-Based Practice Center and"},{"name":"Division of Pediatric Endocrinology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noor","family":"Asi","sequence":"additional","affiliation":[{"name":"Evidence-Based Practice Center and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wigdan","family":"Farah","sequence":"additional","affiliation":[{"name":"Evidence-Based Practice Center and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jehad","family":"Almasri","sequence":"additional","affiliation":[{"name":"Evidence-Based Practice Center and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Barrionuevo","sequence":"additional","affiliation":[{"name":"Evidence-Based Practice Center and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mouaz","family":"Alsawas","sequence":"additional","affiliation":[{"name":"Evidence-Based Practice Center and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[{"name":"Evidence-Based Practice Center and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morey W.","family":"Haymond","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children\u2019s Nutrition Research Center, Baylor College of Medicine, Houston, Texas 77030; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca J.","family":"Brown","sequence":"additional","affiliation":[{"name":"Diabetes, Endocrinology and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Hassan","family":"Murad","sequence":"additional","affiliation":[{"name":"Evidence-Based Practice Center and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2016,12,14]]},"reference":[{"issue":"11","key":"2019041120102809400_B1","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1210\/jc.2011-1159","article-title":"Clinical review: lipodystrophies: genetic and acquired body fat disorders","volume":"96","author":"Garg","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2019041120102809400_B2","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1210\/jc.2012-1872","article-title":"Functional magnetic resonance imaging analysis of food-related brain activity in patients with lipodystrophy undergoing leptin replacement therapy","volume":"97","author":"Aotani","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041120102809400_B3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00005792-200303000-00007","article-title":"Clinical features and metabolic derangements in acquired generalized lipodystrophy: case reports and review of the literature","volume":"82","author":"Misra","year":"2003","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"2019041120102809400_B4","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.md.0000111061.69212.59","article-title":"Clinical features and metabolic and autoimmune derangements in acquired partial lipodystrophy: report of 35 cases and review of the literature","volume":"83","author":"Misra","year":"2004","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"2019041120102809400_B5","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.metabol.2003.10.019","article-title":"Changes in body composition in patients with severe lipodystrophy after leptin replacement therapy","volume":"53","author":"Moran","year":"2004","journal-title":"Metabolism"},{"issue":"4","key":"2019041120102809400_B6","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.2337\/dc13-2040","article-title":"Effects of leptin replacement therapy on pancreatic \u03b2-cell function in patients with lipodystrophy","volume":"37","author":"Muniyappa","year":"2014","journal-title":"Diabetes Care"},{"issue":"3","key":"2019041120102809400_B7","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1210\/jc.2011-2229","article-title":"Comparison of efficacy and safety of leptin replacement therapy in moderately and severely hypoleptinemic patients with familial partial lipodystrophy of the Dunnigan variety","volume":"97","author":"Simha","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2019041120102809400_B8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1034\/j.1399-0004.2002.610407.x","article-title":"Cardiomyopathy in congenital complete lipodystrophy","volume":"61","author":"Bhayana","year":"2002","journal-title":"Clin Genet"},{"issue":"4","key":"2019041120102809400_B9","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1210\/jc.2009-1293","article-title":"LMNA mutations, skeletal muscle lipid metabolism, and insulin resistance","volume":"95","author":"Boschmann","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2019041120102809400_B10","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1210\/jc.2014-4491","article-title":"Partial and generalized lipodystrophy: comparison of baseline characteristics and response to metreleptin","volume":"100","author":"Diker-Cohen","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041120102809400_B11","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1210\/jc.2006-1546","article-title":"Efficacy and safety of leptin-replacement therapy and possible mechanisms of leptin actions in patients with generalized lipodystrophy","volume":"92","author":"Ebihara","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2019041120102809400_B12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/MD.0b013e3181e9442f","article-title":"Cardiomyopathy in congenital and acquired generalized lipodystrophy: a clinical assessment","volume":"89","author":"Lupsa","year":"2010","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"2019041120102809400_B13","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.2337\/dc13-0561","article-title":"Novel forms of lipodystrophy: why should we care?","volume":"36","author":"Rother","year":"2013","journal-title":"Diabetes Care"},{"issue":"1","key":"2019041120102809400_B14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s12020-014-0450-4","article-title":"Recombinant human leptin treatment in genetic lipodystrophic syndromes: the long-term Spanish experience","volume":"49","author":"Araujo-Vilar","year":"2015","journal-title":"Endocrine"},{"issue":"1","key":"2019041120102809400_B15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4103\/0971-6866.132762","article-title":"Berardinelli-Seip syndrome type 1 in an Egyptian child","volume":"20","author":"Metwalley","year":"2014","journal-title":"Indian J Hum Genet"},{"issue":"1","key":"2019041120102809400_B16","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ajhg.2013.06.005","article-title":"Mutations in PIK3R1 cause SHORT syndrome","volume":"93","author":"Dyment","year":"2013","journal-title":"Am J Hum Genet"},{"issue":"9","key":"2019041120102809400_B17","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1002\/ajmg.a.33578","article-title":"Congenital generalized lipodystrophy, type 4 (CGL4) associated with myopathy due to novel PTRF mutations","volume":"152A","author":"Shastry","year":"2010","journal-title":"Am J Med Genet A"},{"issue":"4","key":"2019041120102809400_B18","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1210\/jc.2007-1328","article-title":"Association of a homozygous nonsense caveolin-1 mutation with Berardinelli-Seip congenital lipodystrophy","volume":"93","author":"Kim","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041120102809400_B19","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/1471-2431-14-256","article-title":"Mandibuloacral dysplasia type A-associated progeria caused by homozygous LMNA mutation in a family from Southern China","volume":"14","author":"Luo","year":"2014","journal-title":"BMC Pediatr"},{"issue":"5675","key":"2019041120102809400_B20","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1126\/science.1096706","article-title":"A family with severe insulin resistance and diabetes due to a mutation in AKT2","volume":"304","author":"George","year":"2004","journal-title":"Science"},{"issue":"1","key":"2019041120102809400_B21","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2337\/db14-0104","article-title":"Clinical and molecular characterization of a novel PLIN1 frameshift mutation identified in patients with familial partial lipodystrophy","volume":"64","author":"Kozusko","year":"2015","journal-title":"Diabetes"},{"issue":"6","key":"2019041120102809400_B22","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1399-0004.2008.00992.x","article-title":"Severe mandibuloacral dysplasia caused by novel compound heterozygous ZMPSTE24 mutations in two Japanese siblings","volume":"73","author":"Miyoshi","year":"2008","journal-title":"Clin Genet"},{"issue":"2","key":"2019041120102809400_B23","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.anpedi.2010.09.020","article-title":"[Difficult to manage diabetes mellitus associated with generalized congenital lipodystrophy. Report of two cases]","volume":"74","author":"Cardona-Hern\u00e1ndez","year":"2011","journal-title":"An Pediatr (Barc)"},{"issue":"6","key":"2019041120102809400_B24","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1056\/NEJMoa0706898","article-title":"Phenotype and course of Hutchinson-Gilford progeria syndrome","volume":"358","author":"Merideth","year":"2008","journal-title":"N Engl J Med"},{"issue":"16","key":"2019041120102809400_B25","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1093\/hmg\/ddg213","article-title":"Zinc metalloproteinase, ZMPSTE24, is mutated in mandibuloacral dysplasia","volume":"12","author":"Agarwal","year":"2003","journal-title":"Hum Mol Genet"},{"issue":"5","key":"2019041120102809400_B26","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0022-3476(54)80113-2","article-title":"Leprechaunism: a euphemism for a rare familial disorder","volume":"45","author":"Donohue","year":"1954","journal-title":"J Pediatr"},{"key":"2019041120102809400_B27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/978-3-319-09915-6_18","article-title":"Leptin therapy in patients with lipodystrophy and syndromic insulin resistance","volume-title":"Leptin: Regulation and Clinical Applications","author":"Brown","year":"2015"},{"key":"2019041120102809400_B28"},{"key":"2019041120102809400_B29","unstructured":"U.S. Food and Drug Administration. FDA approves Myalept to treat rare metabolic disease. [New release]. 2014. Available at: http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm387060.htm. Accessed 15 April 2016."},{"issue":"7","key":"2019041120102809400_B30","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.2337\/diabetes.54.7.1994","article-title":"Long-term efficacy of leptin replacement in patients with generalized lipodystrophy","volume":"54","author":"Javor","year":"2005","journal-title":"Diabetes"},{"issue":"1","key":"2019041120102809400_B31","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2337\/diacare.26.1.30","article-title":"Effect of leptin replacement on intrahepatic and intramyocellular lipid content in patients with generalized lipodystrophy","volume":"26","author":"Simha","year":"2003","journal-title":"Diabetes Care"},{"issue":"8","key":"2019041120102809400_B32","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMoa012437","article-title":"Leptin-replacement therapy for lipodystrophy","volume":"346","author":"Oral","year":"2002","journal-title":"N Engl J Med"},{"issue":"9","key":"2019041120102809400_B33","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1210\/jc.2003-031868","article-title":"Effects of exogenous leptin on satiety and satiation in patients with lipodystrophy and leptin insufficiency","volume":"89","author":"McDuffie","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2019041120102809400_B34","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1210\/er.2012-1053","article-title":"Leptin\u2019s role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals","volume":"34","author":"Moon","year":"2013","journal-title":"Endocr Rev"},{"issue":"1","key":"2019041120102809400_B35","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4158\/endp.19.1.v767575m65p5mr06","article-title":"The clinical approach to the detection of lipodystrophy\u2014an AACE consensus statement","volume":"19","author":"Handelsman","year":"2013","journal-title":"Endocr Pract"},{"key":"2019041120102809400_B36","unstructured":"Institute of Medicine of the National Academies. Clinical Practice Guidelines We Can Trust: Standards for Developing Trustworthy Clinical Practice Guidelines (CPGs). 2011. Available at: http:\/\/www.nationalacademies.org\/hmd\/~\/media\/Files\/Report%20Files\/2011\/Clinical-Practice-Guidelines-We-Can-Trust\/Clinical%20Practice%20Guidelines%202011%20Insert.pdf. Accessed 29 June 2016."},{"key":"2019041120102809400_B37","unstructured":"National Guideline Clearinghouse. Criteria for Inclusion of Clinical Practice Guidelines in NGC. 2016. Available at: http:\/\/www.guideline.gov\/about\/inclusion-criteria.aspx. Accessed 29 June 2016."},{"issue":"7","key":"2019041120102809400_B38","doi-asserted-by":"crossref","first-page":"525","DOI":"10.7326\/0003-4819-156-7-201204030-00009","article-title":"Guidelines International Network: toward international standards for clinical practice guidelines","volume":"156","author":"Qaseem","year":"2012","journal-title":"Ann Intern Med"},{"issue":"21","key":"2019041120102809400_B39","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1001\/jama.299.21.2543","article-title":"Patient-important outcomes in registered diabetes trials","volume":"299","author":"Gandhi","year":"2008","journal-title":"JAMA"},{"issue":"11","key":"2019041120102809400_B40","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S1607-551X(10)70094-2","article-title":"A Taiwanese boy with congenital generalized lipodystrophy caused by homozygous Ile262fs mutation in the BSCL2 gene","volume":"26","author":"Huang","year":"2010","journal-title":"Kaohsiung J Med Sci"},{"issue":"9","key":"2019041120102809400_B41","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1210\/jcem.84.9.6103","article-title":"A gene for congenital generalized lipodystrophy maps to human chromosome 9q34","volume":"84","author":"Garg","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2019041120102809400_B42","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/ng585","article-title":"Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13","volume":"28","author":"Magr\u00e9","year":"2001","journal-title":"Nat Genet"},{"issue":"6","key":"2019041120102809400_B43","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.2337\/diabetes.52.6.1573","article-title":"Prevalence of mutations in AGPAT2 among human lipodystrophies","volume":"52","author":"Magr\u00e9","year":"2003","journal-title":"Diabetes"},{"key":"2019041120102809400_B44","doi-asserted-by":"crossref","first-page":"D944","DOI":"10.2741\/A656","article-title":"The structure and functions of human lysophosphatidic acid acyltransferases","volume":"6","author":"Leung","year":"2001","journal-title":"Front Biosci"},{"issue":"2","key":"2019041120102809400_B45","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/hmg\/ddt444","article-title":"BSCL2\/seipin regulates adipogenesis through actin cytoskeleton remodelling","volume":"23","author":"Yang","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"5","key":"2019041120102809400_B46","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S1043-2760(03)00078-X","article-title":"Congenital generalized lipodystrophy: significance of triglyceride biosynthetic pathways","volume":"14","author":"Agarwal","year":"2003","journal-title":"Trends Endocrinol Metab"},{"issue":"6","key":"2019041120102809400_B47","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s10545-005-0038-5","article-title":"Phenotypic heterogeneity in biochemical parameters correlates with mutations in AGPAT2 or Seipin genes among Berardinelli-Seip congenital lipodystrophy patients","volume":"28","author":"Gomes","year":"2005","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"2019041120102809400_B48","first-page":"128","article-title":"Generalized lipodystrophy, infectious mononucleosis, mild infantile hemiplegia","volume":"47","author":"Davis","year":"1954","journal-title":"Proc R Soc Med"},{"key":"2019041120102809400_B49","first-page":"533","article-title":"Lipohistiodiaresis: a syndrome of lipodystrophy universalis, accelerated growth, lipemia, hepatic cirrhosis, and insulin-resistant diabetes without ketosis","volume":"81","author":"Hansen","year":"1961","journal-title":"J Lancet"},{"issue":"12","key":"2019041120102809400_B50","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1001\/archderm.1987.01660360090018","article-title":"Lipoatrophic panniculitis: a possible autoimmune inflammatory disease of fat. Report of three cases","volume":"123","author":"Billings","year":"1987","journal-title":"Arch Dermatol"},{"issue":"1","key":"2019041120102809400_B51","doi-asserted-by":"crossref","first-page":"154","DOI":"10.2214\/ajr.103.1.154","article-title":"The roentgenographic findings in total lipodystrophy","volume":"103","author":"Wesenberg","year":"1968","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"issue":"1","key":"2019041120102809400_B52","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4274\/jcrpe.v2i1.39","article-title":"Acquired generalized lipodystrophy associated with autoimmune hepatitis and low serum C4 level","volume":"2","author":"Eren","year":"2010","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"1","key":"2019041120102809400_B53","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/acr.20015","article-title":"Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients","volume":"62","author":"Ravelli","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"11","key":"2019041120102809400_B54","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.1210\/jc.2003-030835","article-title":"Phenotypic heterogeneity in body fat distribution in patients with congenital generalized lipodystrophy caused by mutations in the AGPAT2 or seipin genes","volume":"88","author":"Simha","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041120102809400_B55","first-page":"358","article-title":"Peculiar distribution of adipose tissue in patients with congenital generalized lipodystrophy","volume":"75","author":"Garg","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041120102809400_B56","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2350-7-3","article-title":"Peroxisomal proliferator activated receptor-gamma deficiency in a Canadian kindred with familial partial lipodystrophy type 3 (FPLD3)","volume":"7","author":"Francis","year":"2006","journal-title":"BMC Med Genet"},{"key":"2019041120102809400_B57"},{"issue":"8","key":"2019041120102809400_B58","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1590\/S0004-27302013000800002","article-title":"[Biochemical, hormonal and genetic evaluation of the families of two Brazilian patients with type 2 familial partial lipodystrophy]","volume":"57","author":"Caldas","year":"2013","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"2019041120102809400_B59"},{"issue":"5","key":"2019041120102809400_B60","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1210\/jcem.86.5.7500","article-title":"Dyslipemia in familial partial lipodystrophy caused by an R482W mutation in the LMNA gene","volume":"86","author":"Schmidt","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041120102809400_B61","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2265.2007.02870.x","article-title":"Familial partial lipodystrophy due to the LMNA R482W mutation with multinodular goitre, extrapyramidal syndrome and primary hyperaldosteronism","volume":"67","author":"Vantyghem","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"163","key":"2019041120102809400_B62","first-page":"343","article-title":"Renal disease in partial lipodystrophy","volume":"41","author":"Eisinger","year":"1972","journal-title":"Q J Med"},{"key":"2019041120102809400_B63","doi-asserted-by":"crossref","first-page":"S455","DOI":"10.4103\/2230-8210.104130","article-title":"Recurrent stroke as a presenting feature of acquired partial lipodystrophy","volume":"16","author":"Prasad","year":"2012","journal-title":"Indian J Endocrinol Metab"},{"issue":"2","key":"2019041120102809400_B64","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1001\/jama.2014.5559","article-title":"How to read a systematic review and meta-analysis and apply the results to patient care: users\u2019 guides to the medical literature","volume":"312","author":"Murad","year":"2014","journal-title":"JAMA"},{"key":"2019041120102809400_B65","doi-asserted-by":"crossref","first-page":"e475","DOI":"10.1038\/tp.2014.115","article-title":"Plasma leptin concentrations are highly correlated to emotional states throughout the day","volume":"4","author":"Licinio","year":"2014","journal-title":"Transl Psychiatry"},{"issue":"2","key":"2019041120102809400_B66","doi-asserted-by":"crossref","first-page":"93","DOI":"10.7326\/0003-4819-152-2-201001190-00008","article-title":"Narrative review: the role of leptin in human physiology: emerging clinical applications","volume":"152","author":"Kelesidis","year":"2010","journal-title":"Ann Intern Med"},{"issue":"2","key":"2019041120102809400_B67","first-page":"245","article-title":"Serum leptin values in the healthy obese and non-obese subjects of Rawalpindi","volume":"63","author":"Kazmi","year":"2013","journal-title":"J Pak Med Assoc"},{"key":"2019041120102809400_B68","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1038\/ijo.2014.133","article-title":"Reference values for leptin and adiponectin in children below the age of 10 based on the IDEFICS cohort","volume":"38","author":"Erhardt","year":"2014","journal-title":"Int J Obes"},{"issue":"8","key":"2019041120102809400_B69","doi-asserted-by":"crossref","first-page":"e72734","DOI":"10.1371\/journal.pone.0072734","article-title":"A meta-analysis of reference values of leptin concentration in healthy postmenopausal women","volume":"8","author":"Zhou","year":"2013","journal-title":"PLoS One"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/102\/2\/363\/10263640\/jc.2016-2271.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T08:47:11Z","timestamp":1692607631000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/102\/2\/363\/2972049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,14]]},"references-count":69,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,12,14]]},"published-print":{"date-parts":[[2017,2,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2016-2271","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,2,1]]},"published":{"date-parts":[[2016,12,14]]}}}